Hyperfine, Inc. (HYPR)
| Market Cap | 57.50M |
| Revenue (ttm) | 11.73M |
| Net Income (ttm) | -40.29M |
| Shares Out | 77.84M |
| EPS (ttm) | -0.55 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 73,752 |
| Open | 0.7300 |
| Previous Close | 0.7312 |
| Day's Range | 0.7201 - 0.7400 |
| 52-Week Range | 0.5327 - 1.9000 |
| Beta | 0.95 |
| Analysts | Strong Buy |
| Price Target | 1.06 (+43.51%) |
| Earnings Date | Aug 7, 2025 |
About HYPR
Hyperfine, Inc., a health technology company, engages in the production, supply, service, and commercialization of magnetic resonance imaging (MRI) products. Its Swoop Portable MR Imaging System produces images at a lower magnetic field strength than conventional MRI scanners. The company also offers support and technical assistance services, as well as Hyperfine Image Viewer, a cloud picture archiving and communication system. It serves intensive care units, neurology offices, emergency departments, and comprehensive and primary stroke accredi... [Read more]
Financial Performance
In 2024, Hyperfine's revenue was $12.89 million, an increase of 16.84% compared to the previous year's $11.03 million. Losses were -$40.72 million, -7.95% less than in 2023.
Financial StatementsAnalyst Forecast
According to 3 analysts, the average rating for HYPR stock is "Strong Buy." The 12-month stock price forecast is $1.06, which is an increase of 43.51% from the latest price.
News
Hyperfine Announces Key Executive Appointments to Strengthen its Leadership Position in AI-Powered Portable MRI
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine appoints Rob Fasciano, PhD, and Rafael O'Halloran, PhD, to help advance AI-powered MRI technology and scale next-gen imaging solutions.
Hyperfine Announces FDA Clearance of a New Next-Generation Swoop® System Powered by Optive AI™ Software, Delivering a Transformative Leap in Image Quality
GUILFORD, Conn.--(BUSINESS WIRE)--FDA clears next-gen Swoop® MRI system with Optive AI™ software, bringing a transformative leap in image quality with enhanced usability and comfort.
Hyperfine Announces FDA Clearance of Optive AI™ Software, Introducing the Most Substantial Image Quality Improvement Ever for the Swoop® System
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the world's first FDA-cleared AI-powered portable M...
Hyperfine, Inc. to Participate in Upcoming Jefferies Global Healthcare Conference
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic ...
Hyperfine, Inc. (HYPR) Q1 2025 Earnings Call Transcript
Hyperfine, Inc. (NASDAQ:HYPR) Q1 2025 Earnings Conference Call May 13, 2025 4:30 PM ET Company Participants Webb Campbell - Investor Relations Maria Sainz - President and Chief Executive Officer Bret...
Hyperfine, Inc. Reports First Quarter 2025 Financial Results
GUILFORD, Conn., May 13, 2025 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered po...
Hyperfine, Inc. to Announce First Quarter 2025 Financial Results on May 13, 2025
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (...
Hyperfine Enrolls Initial Patients in NEURO PMR Study to Evaluate Use of AI-Powered Portable MRI in Neurology Offices
GUILFORD, Conn.--(BUSINESS WIRE)--Study examines clinical utility and patient experience of AI-powered portable MRI in neurology offices.
Hyperfine, Inc. (HYPR) Q4 2024 Earnings Call Transcript
Hyperfine, Inc. (NASDAQ:HYPR) Q4 2024 Results Conference Call March 17, 2025 4:30 PM ET Company Participants Marissa Bych - Gilmartin Group Maria Sainz - President and Chief Executive Officer Brett H...
Hyperfine, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results
GUILFORD, Conn., March 17, 2025 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered ...
Hyperfine, Nvidia Partner To Make Brain MRIs More Affordable
Hyperfine, Inc. HYPR shares are surging on Monday. Hyperfine collaborates with Nvidia to advance portable MRI technology. The partnership aims to improve image quality and reduce scan times.
Hyperfine, Inc. to Announce Fourth Quarter and Full Year 2024 Financial Results on March 17, 2025
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. will report financial results for the fourth quarter and full year 2024 on Monday, March 17, 2025.
Hyperfine Announces $6.0 Million Registered Direct Offering
GUILFORD, Conn.--(BUSINESS WIRE)---- $HYPR--Hyperfine, Inc. (Nasdaq: HYPR) (“Hyperfine” or the “Company”) today announced it has entered into a definitive agreement with investors for the purchase and...
Hyperfine Reports on Growing Evidence for the Use of Swoop® System Images in Stroke Diagnosis Presented at the 2025 International Stroke Conference
GUILFORD, Conn.--(BUSINESS WIRE)---- $HYPR #aipowered--Hyperfine reports on new data at ISC 2025 showcasing the growing potential for using images from AI-powered portable MRI for stroke diagnosis.
Hyperfine Expands Global Market Reach with New Distribution Partnerships in European and Middle Eastern Markets
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. announces global expansion of commercial operations into Turkey, Israel and Saudi Arabia to support Swoop® system expansion plans.
Hyperfine Announces Extensive Clinical Study Coverage at RSNA 2024, Showcasing the Body of Evidence Supporting the Use of the Swoop® System Across Different Sites of Care
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine highlights data and conclusions from eleven abstracts presented at the Radiological Society of North America 2024 Annual Meeting in Chicago.
Hyperfine Announces Strategic Leadership Additions to Drive Growth in Key Business Verticals
GUILFORD, Conn.--(BUSINESS WIRE)--Strategic appointments position Hyperfine to drive the adoption of the Swoop® system in hospital settings and expand into the office setting.
Hyperfine Swoop® Portable MR Brain Imaging System Meets New Standards Recently Issued by CMS-Approved Accrediting Body
GUILFORD, Conn.--(BUSINESS WIRE)--The new MRI standards by the IAC, effective immediately, now include portable MR scanning at the point of care.
Hyperfine Announces Ten Abstracts at RSNA, Highlighting the Expanding Utility and Potential of Portable MR Brain Imaging in Diverse Clinical and Research Settings
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. announces ten scientific abstracts highlighting ultra-low-field imaging will be presented at the RSNA 2024 Annual Meeting.
Hyperfine, Inc. to Participate in Upcoming Investor Conferences
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. to present at the BTIG Digital Health Forum on November 25, 2024 and the Mizuho Healthcare Conference on December 11, 2024.
Hyperfine, Inc. (HYPR) Q3 2024 Earnings Call Transcript
Hyperfine, Inc. (NASDAQ:HYPR) Q3 2024 Earnings Conference Call November 12, 2024 4:30 PM ET Company Participants Marissa Bych - Gilmartin Group Maria Sainz - President and CEO Brett Hale - Chief Admi...
Hyperfine, Inc. Reports Third Quarter 2024 Financial Results
GUILFORD, Connecticut, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portab...
Hyperfine Announces European Launch with CE Approval
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. announces CE approval of its latest generation of AI-powered Swoop® system software under the European Medical Device Regulation.
Hyperfine Announces Alzheimer's Research with Promising Swoop® System Data and Advanced Image Quality
MADRID--(BUSINESS WIRE)--Hyperfine, Inc. announced the presentation of additional research data and images using the Swoop® system to image patients with Alzheimer's disease.
Hyperfine, Inc. to Announce Third Quarter 2024 Financial Results on November 12, 2024
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. announces that it will report financial results for the third quarter 2024 on Tuesday, November 12, 2024.